Baxter International manufactures hospital and acute-care products spanning infusion systems, IV solutions, nutrition and renal therapies. Its equipment and consumables support medication delivery, fluid management and dialysis in clinical settings. The business sells largely to hospitals, clinics and care networks rather than retail consumers. Sterile fluids and connected drug-delivery platforms are long-standing pillars of the portfolio.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 2,810 | — | 91 | — |
| Q3 2025 | 2,835 | — | -46 | — |
| Q4 2025 | 2,974 | — | -1,128 | — |
| Q1 2026 | 2,701 | — | -15 | — |
| Q2 2026 | 2,960 | 5.3% | 126 | 38.5% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Bitmine Immersion Technologies, Inc. (BMNR), Fabrinet (FN), BJ's Wholesale Club Holdings, Inc. (BJ), Globe Life Inc. (GL), Gartner, Inc. (IT), CNA Financial Corporation (CNA)